NDC51079-0322-21: PROPOXYPHENE NAPSYLATE AND ACETA.
PROPOXYPHENE NAPSYLATE AND ACETA. Key specifications include administration: ORAL, special_features: SPECIALLY COATED;ACTIVE MEDICAMENT MEDICINAL STRENGTH:NAPSYLATE EQUIVALENT OF BASE PER MILLIGRAM 50.000, primary_container_type: STRIP, secondary_container_type: BOX, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-040-2286, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | SPECIALLY COATED;ACTIVE MEDICAMENT MEDICINAL STRENGTH:NAPSYLATE EQUIVALENT OF BASE PER MILLIGRAM 50.000 |
| primary_container_type | STRIP |
| secondary_container_type | BOX |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 10.000 TABLETS |
| active_medicament_medicinal_strength | 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT |
| NSN | 6505-01-040-2286 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 TABLETS |
| SECONDARY CONTAINER TYPE | BOX |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | STRIP |
| SPECIAL FEATURES | SPECIALLY COATED;ACTIVE MEDICAMENT MEDICINAL STRENGTH:NAPSYLATE EQUIVALENT OF BASE PER MILLIGRAM 50.000 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
No substitute or cross-reference records for this part.